Genetic susceptibility to head and neck cancer: Interaction between nutrition and mutagen sensitivity

Laryngoscope

Volumn 107, Issue 6, 1997, Pages 765-781

  Schantz, Stimson P ^a   Zhang, Zuo Feng ^a   Spitz, Margaret S ^b   Sun, Ming ^c   Hsu, Tao C ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Mem Sloan Kettering Cancer Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC SUSCEPTIBILITY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADULT; AGED; ALCOHOL DRINKING; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOME BREAKAGE; DISEASE SUSCEPTIBILITY; DNA REPAIR; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; NUTRITION PHYSIOLOGY; REACTIVE OXYGEN SPECIES; RISK FACTORS; SMOKING;

EID: 0030913602     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199706000-00011     Document Type: Article

References (57)

1. Schottenfeld D. The etiology and prevention of aerodigestive cancers. Adv Exp Med Biol 1992;320:1-19.
2. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res 1977;37:4608-22.
3. de Villiers EM, Weidauer H, Otto H, zur Hauzen H. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985;36:575-8.
4. Winn DM. Diet and nutrition in the etiology of cancer. Am J Clin Nutr 1995;61:437S-45S.
5. Strauss BS. Cellular aspects of DNA repair. Adv Cancer Res 1995;45:45-105.
6. Hsu TC. Genetic instability in the human population: a working hypothesis. Hereditas 1983;98:1-11.
7. Hsu TC, Cherry LM, Samann NA. Differential mutagen-susceptibility in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet Cytogenet 1985;17: 307-13.
8. Iqbal ZM, Zohn KW, Ewig AG, Fornace AJ. Single-strand scission and repair of DNA in mammalian cells by bleomycin. Cancer Res 1976;36:3834-8.
9. Sikic BI. Biochemical and cellular determinants of bleomycin cytotoxicity. Cancer Surv 1986;5:82-91.
10. Vig BK, Lewis R. Genetic toxicology of bleomycin. Mutat Res 1978;55:121-45.
11. Wang RY, Hsu TC, Brock WA, Liang J. DNA fragility and repair capability are separate genetic phenotypes: studies on in tu nick translation and chromosome breakage. Int J Oncol 1995;6:51-4.
12. Kuo MT, Hsu TC. Biochemical and cytological studies of bleomycin actions on chromatin and chromosomes. Chromosome 1978;68:229-40.
13. Schantz SP, Hsu TC. Mutagen-induced chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck 1989;11:337-42.
14. Hsu TC. Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Developmental Biol 1987;23:591-603.
15. Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43: 403-9.
16. Spitz MR, Fueger JJ, Beddingfield NA, et al. Chromosome sensitivity to bleomycin-induced mutagenesis in patients with upper aerodigestive cancers: a case-control analysis. Cancer Res 1989;49:4626-38.
17. Spitz MR, Fueger JJ, Halabi S, et al. Mutagen sensitivity in upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 1993;2:329-33.
18. Schantz SP, Hsu TC, Ainslie N, Moser RP. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosomal damage. JAMA 1989; 262:3313-5.
19. Cloos J, Braakhuis BJ, Steen I, et al. Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 1994;56:816-9.
20. Li AT, Wang TD, Yang RT. Pingyangomycin-induced chromosome damage in lymphocytes of laryngeal cancer patients and healthy control subjects. Head Neck 1994;16:510.
21. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-5.
22. Spitz MR, Hoque A, Trizna Z, et al. Mutagen sensitivity as a risk factor for second malignant tumors following malignancies of the upper aerodigestive tract. J Natl Cancer Inst 1994;86:1681-4.
23. Trizna Z, Schantz SP, Hsu TC. Effects of N-acetyl-L-cysteine and ascorbic acid on mutagen-induced chromosomal sensitivity in head and cancer patients. Am J Surg 1991;162: 294-8.
24. Trizna Z, Schantz SP, Lee JJ, et al. In vitro protective effects of chemopreventive agents against bleomycin-induced genotoxicity in lymphoblastoid cell lines and peripheral blood lymphocytes of head and neck cancer patients. Cancer Detect Prevent 1993;17:575-83.
25. Spitz MR, Fueger JJ, Borrud LG, Newell GR. The development of a comprehensive institutional-based patient risk evaluation program. Part I. Development, content, and data management. Am J Prev Med 1988;4:183-7.
26. Block G, Dresser CM, Hartman AM, et al. Nutritional source in the American diet: quantitative data from the NHANES II Survey. Part I. Vitamins and minerals. Am J Epidemiol 1985;122:13-26.
27. Block G, Dresser CM, Hartman AM, et al. Nutrient sources in the American diet: quantitative data from the NHANES II Survey. Part II. Macronutrients and fats. Am J Epidemiol 1985;122:27-40.
28. Block G. A review of validations of dietary assessment methods. Am J Epidemiol 1987;126(5):796-802.
29. National Health and Nutrition Examination Survey II (NHANES II). Hyattsville, MD: National Center for Health Statistics, 1976-1980.
30. Public use data tape documentation. Model gram and nutrient composition. Hyattsville, MD: National Center for Health Statistics, 1982 (computer tapes 5702 and 5703).
31. US Department of Agriculture. Nutrient database for standard reference: expansion of data published in Composition of Foods - Raw, Processed, Prepared. Revisions of Agriculture Handbook No. 8. Hyattsville, MD: US Department of Agriculture, May 1988 (computer tape).
32. Breslow NE, Day NE, eds. Statistical Methods in Cancer Research. Vol 1. The Analysis of Case-Control Studies. Lyon, France: International Agency for Research on Cancer, 1980 (LARC scientific publication no. 32).
33. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
34. Rothman KJ. Synergy and antagonism in cause-effect relationships. Am J Epidemiol 1974;99:385-8.
35. Dayal HH. Additive excess risk model for epidemiologic interaction in retrospective studies. J Chronic Dis 1980;33: 653-60.
36. Schlesselman JJ, ed. Case-Control Studies: Design, Conduct, Analysis. New York, Oxford University Press, 1982: 63-68.
37. Krinsky NI. Actions of carotenoids in biological systems. Annu Rev Nutr 1993;13:561-87.
38. Joenje H. Genetic toxicology of oxygen. Mutat Res 1989;219: 193-208.
39. Buettner GR. The pecking order of free radicals and antioxidants. Arch Biochem Biophys 1993;300:535.
40. Halliwell B. Free radicals, antioxidants, and human disease: where are we now? J Lab Clin Med 1992;119: 598-620.
41. Mullaart E, Lohman PHM, Berendz F, Vijg J. DNA damage: metabolism and aging. Mutat Res 1990;237:189-210.
42. Pryor WA, Stone K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci 1993;686:12-27.
43. Cheng KC, Loeb LA. Genomic instability and tumor progression: mechanistic considerations. Adv Cancer Res 1993;60:121-56.
44. Hoffmann D, and Hecht SS. Advances in tobacco carcinogenesis. In: Grover P, ed. Handbook of Experimental Pharmacology. New York: Spinger Verlag, 1989.
45. Nakayama T, Kaneko M, Kodama M, Nagata C. Cigarette smoke induces DNA single-strand breaks in cells. Nature 1985;314:462-4.
46. Weitberg AB, Corvese D. Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin Genet 1993;43:88-91.
47. Dorr RT. Bleomycin pharmacology: mechanism of action and resistance and clinical pharmacokinetics. Semin Oncol 1992;19(S5):3-8.
48. Vorechovsky I, Munzarova M, Lokaj J. Increased bleomycin-induced chromosome damage in lymphocytes of patients with common variable immunodeficiency indicates an involvement of chromosomal instability in their cancer pre-disposition. Cancer Immunol Immunother 1989;29: 303-6.
49. Povirk LF, Austin MJ. Genotoxicity of bleomycin. Mutat Res 1991;257:127-43.
50. Frei B et al. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994;97(3A): 5S-13S.
51. Krinsky NR. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992;200:248-54.
52. Pohl H, Reidy J. Vitamin C intake influences the bleomycin-induced chromosomal damage assay: implications for detection of cancer susceptibility and chromosome breakage syndromes. Mutat Res 1989;224:247-52.
53. Hsu TC, Furlong C, Spitz MR. Ethyl alcohol as a carcinogen with special reference to the aerodigestive tract: a cytogenetic study. Anticancer Res 1991;11: 1097-102.
54. Hsu TC, Furlong C. The role of ethanol in oncogenesis of the upper aerodigestive tract: inhibition of DNA repair. Anticancer Res 1991;11:1995-8.
55. Kumano A, Kajii T. Synergistic effect of aphidocolin and ethanol on the induction of common fragile sites. Hum Genet 1987;75:75-8.
56. Lin YC, Ho IC, Lee TC. Ethanol and acetaldehyde potentiate the clastogenicity of ultraviolet light, methyl methanesulfonate, mitomycin C, and bleomycin in Chinese hamster ovary cells. Mutat Res 1989;216:93-9.
57. Hsu TC, Ramkissoon D, Furlong C. Differential susceptibility to a mutagen among human individuals: synergistic effect on chromosome damage between bleomycin and aphidicolin. Anticancer Res 1986;6:1171-6.